Pharmaceutical and Medicine Manufacturing in the US

Industry enjoying a new growth cycle

In the midst of a new growth cycle, among the key factors driving growth are new products, new technology and systems, and the emergence of new markets and customers. Going forward, the industry will have to continue to evolve in order to adapt to its changing environment and the increased risks it is currently facing, including legislative, regulatory, product development and reputation risks.

This industry comprises establishments primarily engaged in one or more of the following: (1) manufacturing biological and medicinal products; (2) processing (i.e., grading, grinding, and milling) botanical drugs and herbs; (3) isolating active medicinal principals from botanical drugs and herbs; and (4) manufacturing pharmaceutical products intended for internal and external consumption in such forms as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions. This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.